Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

NCT04667624 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Twynsta
DRUG: LodineT

Sponsor

Hanlim Pharm. Co., Ltd.